Syndax Pharmaceuticals Inc (OQ:SNDX)

Business Focus: Biopharmaceuticals

Competitors with Recent Insider Filings
Biogen (OQ:BIIB)
Allakos (OQ:ALLK)
BioMarin Pharmaceutical (OQ:BMRN)
Latest 10 SEC filings (by transaction date) for SNDX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET September 18th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jul 8/19 Jul 4/19 Metzger Michael A Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 200,000  
Jun 12/19 Jun 10/19 Podlesak Dennis Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 44,000  
Jun 12/19 Jun 10/19 Meury William Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 24,000  
Jun 12/19 Jun 10/19 Legault Pierre Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 24,000  
Jun 12/19 Jun 10/19 Katkin Keith Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 24,000  
Jun 12/19 Jun 10/19 Jarrett Jennifer Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 24,000  
Jun 12/19 Jun 10/19 Egros Fabrice Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 24,000  
May 13/19 May 13/19 Morrison Briggs Direct Ownership Common Stock P - Open market or private purchase 7,200 $7.29
May 13/19 May 9/19 Morrison Briggs Direct Ownership Common Stock P - Open market or private purchase 13,200 $7.56
Mar 25/19 Mar 21/19 Meyers Michael L. Direct Ownership Common Stock P - Open market or private purchase 8 $4.87
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for SNDX within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET September 18th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jul 8/19 Jul 4/19 Metzger Michael A Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 200,000  
Jun 12/19 Jun 10/19 Podlesak Dennis Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 44,000  
Jun 12/19 Jun 10/19 Meury William Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 24,000  
Jun 12/19 Jun 10/19 Legault Pierre Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 24,000  
Jun 12/19 Jun 10/19 Katkin Keith Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 24,000  
Jun 12/19 Jun 10/19 Jarrett Jennifer Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 24,000  
Jun 12/19 Jun 10/19 Egros Fabrice Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 24,000  
May 13/19 May 13/19 Morrison Briggs Direct Ownership Common Stock P - Open market or private purchase 7,200 $7.29
May 13/19 May 9/19 Morrison Briggs Direct Ownership Common Stock P - Open market or private purchase 13,200 $7.56
Mar 25/19 Mar 21/19 Meyers Michael L. Direct Ownership Common Stock P - Open market or private purchase 8 $4.87
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $SNDX

StockTwits